{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:53:54Z","timestamp":1787648034551,"version":"build-2736575974"},"reference-count":15,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"2","content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>La estrongiloidiasis es una enfermedad causada por el nematodo Strongyloides stercoralis, end\u00e9mico en las regiones rurales de los pa\u00edses tropicales y subtropicales. Los pacientes inmunosuprimidos tienen un mayor riesgo de infecci\u00f3n con este par\u00e1sito y pueden terminar desarrollando un s\u00edndrome de hiperinfecci\u00f3n que conlleva un alto riesgo de muerte. En el tratamiento se utiliza la ivermectina, pero, ni en Colombia ni en el mundo, existe una presentaci\u00f3n parenteral del medicamento para uso en humanos, lo cual es un problema en aquellos pacientes que puedan tener comprometida la absorci\u00f3n intestinal, como es el caso de aquellos con obstrucciones intestinales.Se reporta el caso de un s\u00edndrome de hiperinfecci\u00f3n por S. stercoralis en Colombia tratado con ivermectina subcut\u00e1nea; la idea al presentarlo es incentivar los estudios de farmacocin\u00e9tica y farmacodinamia que analicen esta v\u00eda de administraci\u00f3n como alternativa para el tratamiento de pacientes con riesgo de fracaso terap\u00e9utico con la v\u00eda oral.<\/jats:p>","DOI":"10.7705\/biomedica.5140","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T15:00:07Z","timestamp":1594738807000},"page":"228-232","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":4,"title":["Ivermectina subcut\u00e1nea en el tratamiento de un s\u00edndrome de hiperinfecci\u00f3n por Strongyloides stercoralis"],"prefix":"10.7705","volume":"40","author":[{"given":"Diana Carolina","family":"Hennessey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar Andr\u00e9s","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Javier","family":"Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy Orlando","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-3093","authenticated-orcid":false,"given":"Diego Fernando","family":"Severiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"98194","unstructured":"Kassalik M, M\u00f6nkem\u00fcller K. Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Gastroenterol Hepatol. 2011;7:766-8."},{"key":"98195","doi-asserted-by":"crossref","unstructured":"Greaves D, Coggle S, Pollard C, Aliyu SH, Moore EM. Strongyloides stercoralis infection. BMJ. 2013;347:f4610. https:\/\/doi.org\/10.1136\/bmj.f4610","DOI":"10.1136\/bmj.f4610"},{"key":"98196","doi-asserted-by":"crossref","unstructured":"Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49:1411-23. https:\/\/doi.org\/10.1086\/630201","DOI":"10.1086\/630201"},{"key":"98197","doi-asserted-by":"crossref","unstructured":"Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: An emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102:314-8. https:\/\/doi.org\/10.1016\/j.trstmh.2008.01.020","DOI":"10.1016\/j.trstmh.2008.01.020"},{"key":"98198","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Chavarr\u00eda F. Strongyloides stercoralis: un par\u00e1sito subestimado. Parasitol D\u00eda. 2001;25:40-9. https:\/\/doi.org\/10.4067\/S0716-07202001000100008","DOI":"10.4067\/S0716-07202001000100008"},{"key":"98199","doi-asserted-by":"crossref","unstructured":"Sch\u00e4r F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: Global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:e2288. https:\/\/doi.org\/10.1371\/journal.pntd.0002288","DOI":"10.1371\/journal.pntd.0002288"},{"key":"98200","doi-asserted-by":"crossref","unstructured":"Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J, et al. Strongyloidiasis\u2014an insight into its global prevalence and management. PLoS Negl Trop Dis. 2014;8:e3018. https:\/\/doi.org\/10.1371\/journal.pntd.0003018","DOI":"10.1371\/journal.pntd.0003018"},{"key":"98201","doi-asserted-by":"crossref","unstructured":"Buonfrate D, Mena MA, Angheben A, Requena-M\u00e9ndez A, Mu\u00f1oz J, Gobbi F, et al. Prevalence of strongyloidiasis in Latin America: A systematic review of the literature. Epidemiol Infect. 2015;143:452-60. https:\/\/doi.org\/10.1017\/S0950268814001563","DOI":"10.1017\/S0950268814001563"},{"key":"98202","unstructured":"Center for Disease Control and Prevention. Strongyloidiasis. Fecha de consulta: 20 de febrero de 2019. Disponible en: https:\/\/www.cdc.gov\/parasites\/strongyloides\/index.html"},{"key":"98203","doi-asserted-by":"crossref","unstructured":"Llagunes J, Mateo E, Pe\u00f1a JJ, Carmona P, Andr\u00e9s J. Hiperinfecci\u00f3n por Strongyloides stercoralis. Med Intensiva. 2010;34:353-6. https:\/\/doi.org\/10.1016\/j.medin.2009.06.006","DOI":"10.1016\/j.medin.2009.06.006"},{"key":"98204","doi-asserted-by":"crossref","unstructured":"Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: Risk factors, diagnosis and management. CMAJ. 2004;171:479-84. https:\/\/doi.org\/10.1503\/cmaj.1031698","DOI":"10.1503\/cmaj.1031698"},{"key":"98205","doi-asserted-by":"crossref","unstructured":"Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41:1992-2001. https:\/\/doi.org\/10.1345\/aph.1K302","DOI":"10.1345\/aph.1K302"},{"key":"98206","doi-asserted-by":"crossref","unstructured":"Barrett J, Broderick C, Soulsby H, Wade P, Newsholme W. Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: Two case reports and a discussion of the literature. J Antimicrob Chemother. 2016;71:220-5. https:\/\/doi.org\/10.1093\/jac\/dkv315","DOI":"10.1093\/jac\/dkv315"},{"key":"98207","doi-asserted-by":"crossref","unstructured":"Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet. 2000;355:43-4 https:\/\/doi.org\/10.1016\/s0140-6736(99)02744-0","DOI":"10.1016\/S0140-6736(99)02744-0"},{"key":"98208","doi-asserted-by":"crossref","unstructured":"Zeitler K, Jariwala R, Restrepo-Jaramillo R, Kapadia S, Casanas B, Sriaroon C, et al. Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population. BMJ Case Rep. 2018;2018:bcr-2017-223138. https:\/\/doi.org\/10.1136\/bcr-2017-223138","DOI":"10.1136\/bcr-2017-223138"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5140\/4458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5140\/4458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T17:25:36Z","timestamp":1594920336000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,15]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5140","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"2020-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Case presentation","name":"content_type","label":"Content Type"}]}}